Interv Akut Kardiol. 2003;2(4):202-204
Milrinon in the treatment of heart failure refractory to any other pharmacological treatment
- III. interní klinika VFN a 1. LF UK, Praha
Use of positive inotropic phosphodiesterase inhibitor Milrinone in treatment of severe heart failure is known and aviable for several years. In spite of it an exploitation of Milrinone is minimal in the Czech Republic. One reason of this situation next to the higher price is probably a worry of adverse effects and only temporary positive effect of this medication. We have treated with Milrinone repeatedly and successfully patients with severe heart failure refractory to standard treatment. We were successful despite of high age of our patients, unsuitability of revascularisations or other causal treatment and many relative contraindications of Milrinone use. On the four case reports from our practise we illustrate benefit and safety of the use of Milrinone in different complicated situations.
Keywords: Milrinon, heart failure.
Published: December 31, 2003 Show citation
References
- Mehra MR, Venrura HO, Kapoor C, et al. Safety and clinical utility of long-term intravenous milrinone in advanced heart failure. Am J Cardiol 1997; 80: 61-64.
Go to original source... 
Go to PubMed... - Packer M, Carver JR, Rodchefferer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure: the PROMISE Study Research Group. N Engl J Med. 1991; 325: 1468-1475. Go to original source... Go to PubMed...
- Cuffe MS, Califf RM, Adams KF, et al. M. Short-term intravenous milrinone for acute exacerbation of chronic heart failure, JAMA 2002; 287: 1541-1547. Go to original source... Go to PubMed...
- Cuffe MS, Califf RM, Adams KF, et al. for the OPTIMI-CHF Steering Committee. Rational and design of the Outcomes of a prospective trial of intravenous milrinone for exacerbation of chronic heart failure. Am Heart J. 2000; 139: 15-22. Go to original source... Go to PubMed...
- Rector TS, Tschumperlin LK, Kubo SH, Bank AJ, Francis GS, McDonald KM, Keeler CA, Silver MA. Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail. 1995; 1: 201-206. Go to original source... Go to PubMed...
- Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant. 2001; 20: 16-24. Go to original source... Go to PubMed...